BIOTHRAX DIN 02483386
Status: Restricted Access
Holder: EMERGENT BIODEFENSE OPERATIONS LANSING LLC
Molecule: ANTHRAX ANTIGEN FILTRATE
Health Canada record
| Active ingredient(s) | ANTHRAX ANTIGEN FILTRATE 50 MCG |
|---|---|
| Dosage form | Suspension |
| Route | Intramuscular; Subcutaneous |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | J07AC01 ANTHRAX ANTIGEN |
| Original market date | |
| Current status date | 20-Mar-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Emergent BioSolutions Canada Inc. — licence 3-002450, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
Request a quote for BIOTHRAX